27 January 2021 - As the Biden White House attempts to fashion its health policies, a coalition of consumer and patient advocacy groups is urging the administration not to tap Janet Woodcock, a long-standing FDA official, to head the embattled agency.
Woodcock is currently serving as acting FDA commissioner, but has at various times led the division that regulates medicines.